The claim that CJC-1295 with DAC necessarily replaces GH pulses with a completely flat output does not accurately describe the dedicated human pulsatility study. Long-lasting stimulation and pulsatile secretion are not mutually exclusive concepts.
Researchers used repeated overnight blood sampling in healthy men in the CJC-1295 pulsatility study. Pulses persisted, while trough and mean GH levels increased. This is a more specific result than either “perfectly natural” or “constant GH with no pulses.”
A higher floor can coexist with peaks
Imagine a signal with peaks separated by lower values. Raising the lower values can increase the average without erasing the peaks. Pulse frequency, pulse size, trough concentration and average exposure describe different properties of that signal.
That distinction matters when online discussions use “pulsatile” as a synonym for safe. Preserved pulsatility does not show that the entire hormonal environment is unchanged. Nor does it establish that every downstream outcome is beneficial. The study answers a secretion-pattern question, not a lifetime safety question.
Its observation window and participant selection also matter. An overnight assessment in healthy men cannot describe every person's response throughout repeated long-term exposure. It cannot establish comparative outcomes against an unspecified no-DAC preparation because that was not the comparison being tested.
A reader should therefore ask which part of the curve a claim refers to. A higher mean is not proof of more frequent pulses. A preserved peak pattern is not proof of unchanged baseline exposure. Combining those concepts can make two apparently conflicting statements look compatible when they are not.
The useful correction is narrow: the cited study did not show complete loss of GH pulses. That correction should not be turned into an endorsement of CJC DAC, a claim that it is physiologically identical to normal secretion, or a recommendation for a personal regimen. Accurate interpretation keeps the measured finding and the untested clinical consequences separate.
